Lung cancer
Conditions
Interventions
Study group: patients with clinically confirmed or highly suspected malignancy:Targeted tumor microenvironment molecular probe imaging.
Healthy control group:Targeted tumor microenvironment molecular probe imaging.
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Adult patients (aged 18 or above), regardless of gender; 2.Patients with nasopharyngeal cancer, esophageal cancer, and lung cancer diagnosed clinically and pathologically, who have not received any treatment; And agree to undergo histopathological examination (if not performed before imaging); Healthy volunteers; 3.Willing and able to follow schedule visits, treatment plans, laboratory tests, and other related procedures; 4.Agree to probe imaging of key biomarkers for tumor radiotherapy and 18F-FDG PET imaging.
Exclusion criteria
Exclusion criteria: 1.Acute systemic diseases and electrolyte imbalances; 2.Pregnant or lactating women planning to become pregnant within six months; 3.The patient or their legal representative is unable or unwilling to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Standardized uptake values of region of interest; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pathological diagnosis of tumor tissue;Radioactivity in the blood and urine samples; | — |
Countries
China
Contacts
Public ContactXiaoli Lan
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed